(UL) Unilever - Ratings and Ratios
Shampoo, Soap, Deodorant, Ice Cream, Detergent
Dividends
| Dividend Yield | 3.08% |
| Yield on Cost 5y | 3.40% |
| Yield CAGR 5y | -0.05% |
| Payout Consistency | 91.9% |
| Payout Ratio | 96.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 21.3% |
| Value at Risk 5%th | 31.7% |
| Relative Tail Risk | -9.36% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.07 |
| Alpha | -2.83 |
| CAGR/Max DD | 0.40 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.459 |
| Beta | 0.018 |
| Beta Downside | -0.274 |
| Drawdowns 3y | |
|---|---|
| Max DD | 15.93% |
| Mean DD | 6.24% |
| Median DD | 6.33% |
Description: UL Unilever December 02, 2025
Unilever PLC (NYSE: UL) is a global fast-moving consumer goods (FMCG) group operating across four continents and organized into five business segments: Beauty & Wellbeing, Personal Care, Home Care, Foods, and Ice Cream. Its portfolio spans iconic brands such as Dove, Axe, Hellmann’s, Ben & Jerry’s, and Magnum, covering product categories from hair and skin care to detergents, sauces, and frozen desserts.
In FY 2023 the company generated €59.6 billion in revenue with an underlying EBIT margin of roughly 16%, reflecting modest profit-share recovery after a 2022 cost-inflation shock. Growth is now being driven primarily by emerging-market volume gains (≈5% YoY) and premium-priced “beauty-wellbeing” launches, while price-sensitivity in mature markets remains a headwind. Key sector drivers include persistent consumer-price inflation, volatile commodity costs (e.g., palm oil, surfactants), and accelerating e-commerce penetration that is reshaping distribution channels.
Analysts should watch the company’s ability to sustain margin expansion through price-setting power and cost-efficiency programs, as well as currency exposure given the euro-pound and dollar-pound dynamics that can swing earnings materially.
For a deeper dive into UL’s valuation assumptions, scenario modeling, and peer-adjusted metrics, explore the ValueRay UL dashboard.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (12.20b TTM) > 0 and > 6% of Revenue (6% = 7.20b TTM) |
| FCFTA 0.19 (>2.0%) and ΔFCFTA 5.47pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.92% (prev -6.18%; Δ 1.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.24 (>3.0%) and CFO 17.87b > Net Income 12.20b (YES >=105%, WARN >=100%) |
| Net Debt (28.91b) to EBITDA (24.56b) ratio: 1.18 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.76 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (2.45b) change vs 12m ago -3.02% (target <= -2.0% for YES) |
| Gross Margin 43.51% (prev 23.98%; Δ 19.53pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 158.7% (prev 120.5%; Δ 38.27pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 13.98 (EBITDA TTM 24.56b / Interest Expense TTM 1.56b) >= 6 (WARN >= 3) |
Altman Z'' -2.26
| (A) -0.08 = (Total Current Assets 19.19b - Total Current Liabilities 25.10b) / Total Assets 76.00b |
| (B) -0.46 = Retained Earnings (Balance) -35.14b / Total Assets 76.00b |
| (C) 0.29 = EBIT TTM 21.77b / Avg Total Assets 75.63b |
| (D) -2.08 = Book Value of Equity -120.89b / Total Liabilities 58.20b |
| Total Rating: -2.26 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 78.63
| 1. Piotroski 8.0pt |
| 2. FCF Yield 9.41% |
| 3. FCF Margin 12.05% |
| 4. Debt/Equity 1.80 |
| 5. Debt/Ebitda 1.18 |
| 6. ROIC - WACC (= 44.16)% |
| 7. RoE 64.03% |
| 8. Rev. Trend 12.45% |
| 9. EPS Trend -11.90% |
What is the price of UL shares?
Over the past week, the price has changed by -4.25%, over one month by +0.55%, over three months by -4.34% and over the past year by +2.81%.
Is UL a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the UL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 71.4 | 14% |
| Analysts Target Price | 71.4 | 14% |
| ValueRay Target Price | 64 | 2.2% |
UL Fundamental Data Overview January 01, 2026
P/E Trailing = 22.0943
P/E Forward = 17.0068
P/S = 2.4037
P/B = 6.846
P/EG = 1.9325
Beta = 0.215
Revenue TTM = 120.06b EUR
EBIT TTM = 21.77b EUR
EBITDA TTM = 24.56b EUR
Long Term Debt = 24.87b EUR (from longTermDebt, last quarter)
Short Term Debt = 7.16b EUR (from shortTermDebt, last quarter)
Debt = 32.02b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 28.91b EUR (from netDebt column, last quarter)
Enterprise Value = 153.77b EUR (122.98b + Debt 32.02b - CCE 1.23b)
Interest Coverage Ratio = 13.98 (Ebit TTM 21.77b / Interest Expense TTM 1.56b)
FCF Yield = 9.41% (FCF TTM 14.47b / Enterprise Value 153.77b)
FCF Margin = 12.05% (FCF TTM 14.47b / Revenue TTM 120.06b)
Net Margin = 10.16% (Net Income TTM 12.20b / Revenue TTM 120.06b)
Gross Margin = 43.51% ((Revenue TTM 120.06b - Cost of Revenue TTM 67.82b) / Revenue TTM)
Gross Margin QoQ = 100.0% (prev -12.64%)
Tobins Q-Ratio = 2.02 (Enterprise Value 153.77b / Total Assets 76.00b)
Interest Expense / Debt = 1.18% (Interest Expense 377.0m / Debt 32.02b)
Taxrate = 25.17% (1.28b / 5.09b)
NOPAT = 16.29b (EBIT 21.77b * (1 - 25.17%))
Current Ratio = 0.76 (Total Current Assets 19.19b / Total Current Liabilities 25.10b)
Debt / Equity = 1.80 (Debt 32.02b / totalStockholderEquity, last quarter 17.79b)
Debt / EBITDA = 1.18 (Net Debt 28.91b / EBITDA 24.56b)
Debt / FCF = 2.00 (Net Debt 28.91b / FCF TTM 14.47b)
Total Stockholder Equity = 19.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.05% (Net Income 12.20b / Total Assets 76.00b)
RoE = 64.03% (Net Income TTM 12.20b / Total Stockholder Equity 19.05b)
RoCE = 49.58% (EBIT 21.77b / Capital Employed (Equity 19.05b + L.T.Debt 24.87b))
RoIC = 49.16% (NOPAT 16.29b / Invested Capital 33.14b)
WACC = 5.01% (E(122.98b)/V(155.01b) * Re(6.08%) + D(32.02b)/V(155.01b) * Rd(1.18%) * (1-Tc(0.25)))
Discount Rate = 6.08% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -100.0 | Cagr: -1.52%
[DCF Debug] Terminal Value 81.43% ; FCFE base≈12.77b ; Y1≈15.76b ; Y5≈26.88b
Fair Price DCF = 209.7 (DCF Value 457.22b / Shares Outstanding 2.18b; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -11.90 | EPS CAGR: -61.30% | SUE: 0.0 | # QB: 0
Revenue Correlation: 12.45 | Revenue CAGR: 6.40% | SUE: N/A | # QB: 0
EPS next Year (2026-12-31): EPS=3.10 | Chg30d=-0.400 | Revisions Net=-3 | Growth EPS=+8.0% | Growth Revenue=+2.0%
Additional Sources for UL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle